Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest solid tumors and is estimated to become a leading cause of cancer-related death in coming years. Despite advances in surgical approaches and the emergence of new chemotherapy options, its poor prognosis has not improved in the last decades. The current treatment for PDAC is the combina...
Alternative Titles
Full title
Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_26d9e63f0eca4feeada67d37bbc32860
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_26d9e63f0eca4feeada67d37bbc32860
Other Identifiers
ISSN
2075-1729
E-ISSN
2075-1729
DOI
10.3390/life11080843
